In the early stages of cancer development, TGF-β signalling functions as a tumour suppressor by inhibiting cell cycle progression from G1 to S phase and inducing apoptosis, senescence and differentiation [2,5,8,9]. This evidence concerns the gene TGFB1 and neoplasm.